Zhejiang Jianfeng (SHA:600668) received drug registration certificates from China's National Medical Products Administration for two drugs, according to a Shanghai bourse filing on Friday.
The certificates are for vonoprazan fumarate tablets, which is used to treat gastric ulcer, duodenal ulcer and reflux esophagitis, and azilsartan potassium tablets, which lowers blood pressure.